Xuzhou, China Clinical Trials

A listing of Xuzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis

This is a multicentre prospective, randomized, double-blind and imitation, positive-drug parallel controlled clinical trail. The objective of this study is to evaluate the efficacy and safety of Huaiqihuang Granule in patients with CKD stage 3 primary glomerulonephritis.

Qilu Hospital of Shandong University
 (169.8 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +37 other locations
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

This study is to evaluate the safety and efficacy of 60mg ticagrelor plus 100mg Aspirin to prevent major adverse cardiovascular and cerebrovascular events in one years after drug-eluting stents implantation for Chinese ACS patients compared with 90mg ticagrelor plus 100mg Aspirin

ticagrelor
acute coronary syndrome
aspirin
percutaneous coronary intervention
The third people's hospital
 (6.7 away) Contact site
  • 4 views
  • 19 Jun, 2021
  • +7 other locations
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate the efficacy and safety of Kanglaite Injection for advanced non-small cell lung cancer(NSCLC).

cancer chemotherapy
gemcitabine
carboplatin
paclitaxel
lung carcinoma
Xuzhou Central Hospital
 (6.1 away) Contact site
  • 0 views
  • 01 Mar, 2021
  • +16 other locations
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D

The purpose of this study is to generate effectiveness data of ARNI, in the Chinese HFrEF patients with implanted ICD or CRT-D. This will be a multicenter, interventional, open-label, and prospective single-arm study to evaluate the effect of ARNI on VAs in approximately 275 HFrEF patients receiving ICD or CRT-D …

angiotensin ii receptor antagonists
Novartis Investigative Site
 (6.5 away) Contact site
  • 0 views
  • 01 Apr, 2021
  • +15 other locations